BizHealthcare - 07/01/2020
"Medical schemes in South Africa are facing a watershed moment with the imminent threat to their future role and overall existence under the National Health Insurance (NHI). By contrast, the prospect of a new age of technology will drive competition, based on efficiencies, value and innovation for the benefit of patients.
The Health Market Inquiry’s recommendations will pave the way towards a patient-centred, value-based healthcare regime. Patients whose doctors are empowered with good quality information have better outcomes and unnecessary healthcare expenditure is reduced.
In 2020, the reforms promised by the regulator to provide a framework for a low-cost benefit option (LCBO) which would address some of the inequities in healthcare in the country, may also materialise. The current legislation makes medical scheme contributions unaffordable for many people. Schemes are ready and waiting to introduce low-cost options that would enable four-million more South Africans to have access to private sector cover, thus relieving an enormous burden on the state sector.
The new age of healthcare
Technology will be a key driver to improving access to more efficient medical care and enhancing treatment efficacy in the coming decade. While the digital era promises to drastically improve operational efficiency and patient outcomes, these innovations can often be costly and may have a negative impact on the economics of healthcare including in the health funding industry. On the other hand, there are great opportunities for efficiencies through better coordination of care and digital health strategies.
Innovations, ranging from artificial intelligence, robotics, machine vision, genomics and precision medicine, will change the healthcare landscape in the next 10 years.
In South Africa, where a quadruple burden of disease puts severe pressure on healthcare budgets, telemedicine can be a saviour in delivering healthcare to underserved communities and these capabilities are continuously being enhanced by new innovations and developments. The National Department of Health has successfully rolled out several large-scale tech-driven initiatives. One of these, MomConnect, uses mobile technology to provide information on pregnancy and childbirth. Once the baby has been delivered, the information provided changes to that of caring for a newborn.
Genomics will be another gamechanger in the coming years and will help in determining personalisation of treatment plans and medicines. In the treatment of cancer, DNA sequencing technology has enabled the development of therapies to treat particular mutations of genes. She adds that immunotherapy, which reprogrammes the patient’s own immune cells to attack the cancer cells, will also rise to the fore of personalised cancer treatment in the near future."
Read more:
https://www.bizcommunity.com/Article/196/733/199407.html#more
